Cargando…
Placental protein 13 (PP13) stimulates rat uterine vessels after slow subcutaneous administration
INTRODUCTION: Reduced concentrations of placental protein 13 (PP13) during the first trimester of human pregnancy are associated with elevated risk for the subsequent development of preeclampsia, which is one of the deadliest obstetrical complications of pregnancy. Previous studies by our group have...
Autores principales: | Drobnjak, Tijana, Jónsdóttir, Anna Margrét, Helgadóttir, Helga, Runólfsdóttir, Margrét Soffía, Meiri, Hamutal, Sammar, Marei, Osol, George, Mandalà, Maurizio, Huppertz, Berthold, Gizurarson, Sveinbjörn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443218/ https://www.ncbi.nlm.nih.gov/pubmed/30988643 http://dx.doi.org/10.2147/IJWH.S188303 |
Ejemplares similares
-
Pharmacokinetics of placental protein 13 after intravenous and subcutaneous administration in rabbits
por: Drobnjak, Tijana, et al.
Publicado: (2018) -
Galectin 13 (PP13) Facilitates Remodeling and Structural Stabilization of Maternal Vessels during Pregnancy
por: Sammar, Marei, et al.
Publicado: (2019) -
The Role of the Carbohydrate Recognition Domain of Placental Protein 13 (PP13) in Pregnancy Evaluated with Recombinant PP13 and the DelT(221) PP13 Variant
por: Sammar, Marei, et al.
Publicado: (2014) -
Personalized Therapy Against Preeclampsia by Replenishing Placental Protein 13 (PP13) Targeted to Patients With Impaired PP13 Molecule or Function
por: Meiri, Hamutal, et al.
Publicado: (2017) -
Placental Protein 13 (PP13) – A Placental Immunoregulatory Galectin Protecting Pregnancy
por: Than, Nándor Gábor, et al.
Publicado: (2014)